Novo Integrated Sciences Net Profit Margin 2012-2024 | NVOS
Novo Integrated Sciences net profit margin from 2012 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Novo Integrated Sciences Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2024-02-29 |
$0.01B |
$-0.01B |
-92.31% |
| 2023-11-30 |
$0.01B |
$-0.01B |
-107.69% |
| 2023-08-31 |
$0.01B |
$-0.01B |
-108.33% |
| 2023-05-31 |
$0.00B |
$-0.03B |
-3200.00% |
| 2023-02-28 |
$0.01B |
$-0.04B |
-291.67% |
| 2022-11-30 |
$0.01B |
$-0.04B |
-291.67% |
| 2022-08-31 |
$0.01B |
$-0.03B |
-275.00% |
| 2022-05-31 |
$0.02B |
$-0.01B |
-56.52% |
| 2022-02-28 |
$0.01B |
$-0.01B |
-81.82% |
| 2021-11-30 |
$0.01B |
$-0.01B |
-50.00% |
| 2021-08-31 |
$0.01B |
$-0.00B |
-44.44% |
| 2021-05-31 |
$0.01B |
$-0.01B |
-75.00% |
| 2021-02-28 |
$0.01B |
$-0.01B |
-85.71% |
| 2020-11-30 |
$0.01B |
$-0.01B |
-85.71% |
| 2020-08-31 |
$0.01B |
$-0.01B |
-62.50% |
| 2020-05-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2020-02-29 |
$0.01B |
$-0.00B |
-11.11% |
| 2019-11-30 |
$0.01B |
0 |
0.00% |
| 2019-08-31 |
$0.01B |
0 |
0.00% |
| 2019-05-31 |
$0.01B |
0 |
0.00% |
| 2019-02-28 |
$0.01B |
0 |
0.00% |
| 2018-11-30 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-08-31 |
$0.01B |
$-0.00B |
-12.50% |
| 2018-05-31 |
$0.01B |
$-0.00B |
-25.00% |
| 2018-02-28 |
$0.01B |
$-0.00B |
-25.00% |
| 2017-08-31 |
$0.01B |
$-0.00B |
-16.67% |
| 2016-11-30 |
$0.00B |
0 |
0.00% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Outpatient & Home Care |
$0.010B |
$0.013B |
|
Novo Integrated Sciences Inc. is a provider of multi-dimensional primary healthcare services and products principally in Canada and the U.S. It deliver or intend to deliver, multidisciplinary primary health care related services and products through the integration of medical technology, advanced therapeutics and rehabilitative science, through its subsidiaries. Novo Integrated Sciences Inc. is based in Bellevue, Washington.
|
